Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.

Studies have shown that GLP-1s reduce inflammation in the brain and regulate anxiety as well as depression. When insurance ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...

The best metric is not weight, but a particularly toxic kind of fat.

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial. The Fox Medical Team's Dr. Mike Cirigliano joined Good Day to take a look ...

Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Two patients with MASH share their paths to diagnosis, including the challenges they faced and what it took to find answers.

Patients lost an average of 18.4 centimeters around their waists on Zepbound and 13 centimeters on Wegovy. Belly fat is ...